[
  {
    "ts": "2025-12-24T12:00:00+00:00",
    "headline": "Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration",
    "summary": "CAMBRIDGE, Mass. & MONTREAL, December 24, 2025--Repare Therapeutics Inc. (\"Repare\" or the \"Company\") (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to acquire Repare’s polymerase theta (Polθ) ATPase inhibitor, RP-3467 (the \"Gilead Agreement\").",
    "url": "https://finance.yahoo.com/news/repare-therapeutics-announces-acquisition-pol-120000560.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a1fb2154-91c8-3338-b3ba-6536ba3c06b5",
      "content": {
        "id": "a1fb2154-91c8-3338-b3ba-6536ba3c06b5",
        "contentType": "STORY",
        "title": "Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration",
        "description": "",
        "summary": "CAMBRIDGE, Mass. & MONTREAL, December 24, 2025--Repare Therapeutics Inc. (\"Repare\" or the \"Company\") (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to acquire Repare’s polymerase theta (Polθ) ATPase inhibitor, RP-3467 (the \"Gilead Agreement\").",
        "pubDate": "2025-12-24T12:00:00Z",
        "displayTime": "2025-12-24T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/repare-therapeutics-announces-acquisition-pol-120000560.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/repare-therapeutics-announces-acquisition-pol-120000560.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RPTX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]